{
    "code": 0,
    "data": [
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Earnings Call for Unaudited Financial Results of quarter and nine months ended December 31 2025 is enclosed herewith.",
            "news_id": "01693110-3898-4a52-9186-d6eaccdb7556",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9090e14f-1642-45a2-b13d-218a950f9f0a.pdf",
            "news_date": "2026-02-10 16:25:01",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Earnings Call for Unaudited Financial Results of quarter and nine months ended December 31 2025 is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9090e14f-1642-45a2-b13d-218a950f9f0a.pdf",
            "news_date": "2026-02-10 16:25:01"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of Unaudited Financial Results for the quarter and nine months ended December 31 2025 is enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e4d9f04-528c-4858-8862-25315ffa368d.pdf",
            "news_date": "2026-02-10 13:11:44"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release for Unaudited Financial Results for quarter and nine months ended December 31 2025 is enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17259a98-8dd3-43be-a9b9-62b70dda8477.pdf",
            "news_date": "2026-02-10 13:06:14"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Results Earnings Call for Quarter and Nine Months ended on December 31 2025 is enclosed herewith.\r\n\r\nKindly take the same on record.",
            "news_id": "06afdd55-0c4a-4ec7-bcd7-1b71a8d0f845",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f43b1341-6a7f-425c-80a9-4b8b6887590c.pdf",
            "news_date": "2026-02-09 19:58:49",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Results Earnings Call for Quarter and Nine Months ended on December 31 2025 is enclosed herewith.\r\n\r\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f43b1341-6a7f-425c-80a9-4b8b6887590c.pdf",
            "news_date": "2026-02-09 19:58:49"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Details of Appointment and Re-appointment of independent Directors of the Company are enclosed herewith.\r\n\r\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d5248a28-33f0-4d63-bd74-daecc06711b7.pdf",
            "news_date": "2026-02-09 19:39:07"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result Quarter Ended On December 31 2025",
            "news_body": "Financial Results for Quarter and Nine Months ended on December 31 2025.",
            "news_id": "c8084638-719f-4afc-9820-08e4e4d03494",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7016a6c6-13cd-4728-8112-652184e7d3e3.pdf",
            "news_date": "2026-02-09 19:28:02",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Result Quarter Ended On December 31 2025",
            "news_body": "Financial Results for Quarter and Nine Months ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7016a6c6-13cd-4728-8112-652184e7d3e3.pdf",
            "news_date": "2026-02-09 19:28:02"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for  Outcome Of Board Meeting Held On February 09 2026",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its Meeting held on Monday February 09 2026 inter-alia considered and approved the following: Unaudited Financial Results Change in Directorate - Appointment/ Re-appointment of Independent Directors Reconstitution of Committees of the Board.\r\nThe details under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read along with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11 2024 are enclosed herewith.\r\n\r\nThe Meeting of the Board of Directors of the Company commenced at 03:00 p.m. and concluded at 05.00 p.m.\r\n\r\nKindly take the above information on your records.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0f84cf7-715b-40e3-b3cd-4001fb644651.pdf",
            "news_date": "2026-02-09 19:18:36"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that an earnings call will be held on Tuesday February 10 2026 at 11.00 A.M. IST to discuss operational and financial performance of the Company for the quarter and nine months ended December 31 2025. \r\n\r\nThe invite giving requisite details including the pre-registration link and dial-in details is enclosed herewith. \r\n\r\nThe investor presentation shall be shared with the Exchanges separately.\r\n\r\nKindly take the information on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3d8d6b1-ebd2-45a2-aba1-3c2e1682ce16.pdf",
            "news_date": "2026-02-04 12:46:41"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this to inform you that a meeting of the Board of Directors of the Company will be held on Monday February 09 2026 inter alia to Consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025. \r\n\r\nThis is to further inform you that in accordance with the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in securities of the Company by Designated Persons and their immediate relatives is closed from January 01 2026 till 48 hours after declaration of Unaudited Financial Results on February 09 2026.\r\n\r\nKindly take the above information on your records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00e0fb41-667b-4894-8835-1cc8196da7ff.pdf",
            "news_date": "2026-02-02 17:37:33"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74 (5) of SEBI (Depositories & Participants) Regulations 2018 for quarter ended December 31 20205 is enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fffaa3e-f192-4684-a055-fc5291785fbb.pdf",
            "news_date": "2026-01-06 16:12:17"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Intimation on Credit Rating to the Company is enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de2090b4-82a9-42de-bba9-9e0e367b520c.pdf",
            "news_date": "2025-12-30 15:40:45"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for Closure of Trading Window for declaration of the Unaudited Financial Results for quarter and nine months ending on December 31 2025.\r\n\r\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f52cf096-9cf8-4735-bd84-824575fc81f3.pdf",
            "news_date": "2025-12-28 23:36:40"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to the relevant provisions of the SEBI Listing Regulations we would like to inform you that the officials of our Company Supriya Lifescience Limited (Company) will be interacting with Analyst/Institutional Investors on Tuesday December 2 2025 as per details attached herewith.\r\n\r\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f0952d5-c3a2-435e-baea-4e7e06ed3463.pdf",
            "news_date": "2025-11-26 17:24:07"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30 2025 is enclosed herewith.\r\n\r\nKindly take the same on record.",
            "news_id": "b72d6096-cca5-4250-b1e3-9e209ca3a84f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea39e12f-cd9e-4ee7-8104-4c8b6a6b34ce.pdf",
            "news_date": "2025-11-18 10:48:21",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30 2025 is enclosed herewith.\r\n\r\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea39e12f-cd9e-4ee7-8104-4c8b6a6b34ce.pdf",
            "news_date": "2025-11-18 10:48:21"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication for the Unaudited Financial Results for the Quarter and Half year ended September 30 2025 is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed464d7e-dcfc-4638-a8fb-6b2e9a597606.pdf",
            "news_date": "2025-11-13 17:48:37"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording for the Earnings Call for Unaudited Financial Results for the quarter and half year ended September 30 2025 is enclosed herewith.",
            "news_id": "2c0b56ab-c111-4dbf-89e3-0b317536f88d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18653b41-e7e7-4e7b-ad52-76255c30bdb9.pdf",
            "news_date": "2025-11-13 17:20:10",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording for the Earnings Call for Unaudited Financial Results for the quarter and half year ended September 30 2025 is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18653b41-e7e7-4e7b-ad52-76255c30bdb9.pdf",
            "news_date": "2025-11-13 17:20:10"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release for the Unaudited Financial Results for the Quarter and Half Year ended September 30 2025 is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f005c5ed-07b4-415b-ba05-050a9fd3dfa2.pdf",
            "news_date": "2025-11-13 14:42:05"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation is enclosed herewith.",
            "news_id": "17a3f7da-4090-448d-a87d-c79968c427cc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=980590cc-304e-4c6f-a027-74dbbb48480e.pdf",
            "news_date": "2025-11-12 18:02:05",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=980590cc-304e-4c6f-a027-74dbbb48480e.pdf",
            "news_date": "2025-11-12 18:02:05"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Unaudited Financial Results for the Quarter and Half year ended September 302025 are enclosed herewith.\r\n\r\nKindly take the same on record.",
            "news_id": "dd45aad8-7e72-421d-98be-fdc552d13c81",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9f31753-611c-4ddd-80c8-a79d0253522e.pdf",
            "news_date": "2025-11-12 17:25:35",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Unaudited Financial Results for the Quarter and Half year ended September 302025 are enclosed herewith.\r\n\r\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9f31753-611c-4ddd-80c8-a79d0253522e.pdf",
            "news_date": "2025-11-12 17:25:35"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On November 12 2025",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its Meeting held on Wednesday November 12 2025 inter-alia considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30 2025. A copy of the same is enclosed along with the Limited Review Report of the Statutory Auditors thereon in terms of SEBI (LODR) Regulations 2015.\r\n\r\nThe Meeting of the Board of Directors of the Company commenced at 03:00 p.m. and concluded at 03.30 p.m.\r\n\r\nKindly take the above information on your records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=370d8fe1-5d0f-41c8-860a-80136dcbfda6.pdf",
            "news_date": "2025-11-12 17:10:51"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that an earnings call will be held on Thursday November 13 2025 at 11.00 A.M. IST to discuss operational and financial performance of the Company for the quarter and half year ended September 30 2025. \r\nThe invite giving requisite details including the pre-registration link and dial-in details is enclosed herewith. \r\n\r\nThe investor presentation shall be shared with the Exchanges separately.\r\n\r\nKindly take the information on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4b94590-d4b0-44c1-bbc8-1d07d88a2847.pdf",
            "news_date": "2025-11-09 23:17:49"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for To Consider And Approve Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday November 12 2025 inter alia to Consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30 2025. \r\n\r\nThis is to further inform you that in accordance with the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in securities of the Company by Designated Persons and their immediate relatives is closed from October 1 2025 till 48 hours after declaration of Unaudited Financial Results on November 12 2025.\r\n\r\nKindly take the above information on your records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9e0b242-5356-4be2-92ee-42f0461ba697.pdf",
            "news_date": "2025-11-05 20:31:21"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find enclosed herewith duly signed certificate dated October 7 2025 issued by MUFG Intime India Pvt. Ltd. our RTA confirming compliance under Regulation 74(5) of SEBI (Depository and Participants) Regulations 2018 for the quarter ended September 30 2025.\r\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e6089d1-d9f3-4de9-bfff-73960b19b189.pdf",
            "news_date": "2025-10-13 11:53:34"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Completion of WHO GMP audit at Ambernath facility of the Company and receipt of WHO GMP Certificate for Inhalation Dosages.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76810869-c577-4e9a-9082-a3cfb643049a.pdf",
            "news_date": "2025-10-01 12:47:24"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The intimation of closure of Trading Window for trading in securities of the Company by Designated Persons and their immediate relatives for the quarter and half year ending on September 30 2025 is effective from October 1 2025.\r\n\r\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c8ec2fc-1af9-4ac8-8ad2-80fd79289da3.pdf",
            "news_date": "2025-09-26 16:46:39"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Voting Results For 17Th Annual General Meeting",
            "news_body": "Brief Proceedings along with Voting Results of 17th AGM is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49ce5813-4917-4cf6-b983-c3b8d862ec0d.pdf",
            "news_date": "2025-09-24 18:38:26"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Scrutinizers Report for 17th AGM is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e916da5-6816-46f6-85a9-877ff3fa0044.pdf",
            "news_date": "2025-09-24 18:33:39"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Outcome of AGM along with Proceedings Scrutinizers Report and Voting Results is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60100001-5b33-42eb-b1aa-7dfcc90f6e57.pdf",
            "news_date": "2025-09-24 18:31:10"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Details of the Analyst / Institutional Investor Meet scheduled on September 23 2025 in which the Company shall participate are attached.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fbd16905-702a-4498-b60d-e6d98584f11a.pdf",
            "news_date": "2025-09-17 16:30:40"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Enclosed herewith is a copy of Newspaper Publication regarding intimation of dispatch of Annual Report AGM Notice and E-voting Instructions.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=775df369-863c-4fa3-82ea-6483cabdcd71.pdf",
            "news_date": "2025-09-02 14:34:04"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Regarding Letter Dispatched To The Shareholders Of The Company Providing Weblink",
            "news_body": "Enclosed herewith is the Letter dispatched by the Company to the Shareholders whose email ids are not registered with the Company / Depositories / RTA.\r\n\r\nKindly take the same on records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80942625-43dd-4f3f-b2ed-7940ce7cb34a.pdf",
            "news_date": "2025-09-02 14:25:11"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Business Responsibility and Sustainability Report of the Company forming part of Annual Report for FY 2024-25 is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd7e40e1-eb93-4e3c-b2cb-4362e0621326.pdf",
            "news_date": "2025-09-01 19:28:02"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report of the Company for FY 2024-25 is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2acb789e-8958-4c5d-8131-d0677177f399.pdf",
            "news_date": "2025-09-01 19:17:57"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 17Th Annual General Meeting Of Members Of The Company Scheduled To Be Held On Wednesday September 24 2025.",
            "news_body": "Enclosed herewith is the Notice convening the 17th Annual General Meeting of Members of the Company scheduled to be held on Wednesday September 24 2025 at 3.00 pm. through Video Conferencing (\"VC\")/ Other Audio Video Means (\"OAVM\").",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72e5af9d-436f-4d80-bf1f-dcd104ae45ac.pdf",
            "news_date": "2025-09-01 19:06:27"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper extract enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=beacff45-6ade-4744-9df8-ed32188c6736.pdf",
            "news_date": "2025-09-01 13:32:22"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of Record Date For 17Th AGM Of The Company Scheduled On September 24 2025.",
            "news_body": "Intimation of Record date of the Company for 17th AGM scheduled on September 24 2025 is attached.\r\n\r\nRequest you to kindly take the same on records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1ac3210-1587-4871-adea-78c100a7085a.pdf",
            "news_date": "2025-08-30 17:24:56"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find Transcript for the Earnings Call held on August 14 2025.",
            "news_id": "989f0707-c138-492a-8a2b-38c5bdba6000",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98638ed4-8a32-42e3-8bb4-6fe69b1ae22c.pdf",
            "news_date": "2025-08-19 14:53:23",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find Transcript for the Earnings Call held on August 14 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98638ed4-8a32-42e3-8bb4-6fe69b1ae22c.pdf",
            "news_date": "2025-08-19 14:53:23"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached herewith Audio Recording of the Earnings Call held today on August 14 2025",
            "news_id": "a8a7489c-7c73-434d-b883-8c9aacb90597",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e84c001f-2ff2-4023-9b5b-ac3a9933b6cd.pdf",
            "news_date": "2025-08-14 16:44:14",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached herewith Audio Recording of the Earnings Call held today on August 14 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e84c001f-2ff2-4023-9b5b-ac3a9933b6cd.pdf",
            "news_date": "2025-08-14 16:44:14"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith Newspaper Publication of Unaudited Financial Results for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a757a85-1b43-4300-ac32-0372ccfc2b67.pdf",
            "news_date": "2025-08-14 16:37:14"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release for the Unaudited Financial Results for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a89af509-1551-408b-aabc-e8c28341c9da.pdf",
            "news_date": "2025-08-14 15:53:45"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter ended June 30 2025",
            "news_id": "a14adffe-c75f-4fab-a6b8-b986a7c244f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=585d7f44-4faf-41d5-ae35-e95cfbb287a2.pdf",
            "news_date": "2025-08-13 18:28:28",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=585d7f44-4faf-41d5-ae35-e95cfbb287a2.pdf",
            "news_date": "2025-08-13 18:28:28"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Amendment In Policy/Code Of The Company",
            "news_body": "The Company at its meeting held on August 13 2025 has approved revised policy/code of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1e7a064-9955-4639-8492-441bbcd221af.pdf",
            "news_date": "2025-08-13 18:14:00"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For The Quarter Ended On June 30 2025",
            "news_body": "Unaudited Financial Results for the quarter ended June 30 2025.\r\n\r\nKindly take the same on record.",
            "news_id": "794dd689-da94-447b-930c-516aaa805dcb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d428a80-9f64-46c6-89ac-a37801df9724.pdf",
            "news_date": "2025-08-13 18:00:33",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Result For The Quarter Ended On June 30 2025",
            "news_body": "Unaudited Financial Results for the quarter ended June 30 2025.\r\n\r\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d428a80-9f64-46c6-89ac-a37801df9724.pdf",
            "news_date": "2025-08-13 18:00:33"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On August 13 2025",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its Meeting held on Wednesday August 13 2025 inter-alia considered and approved the following:\r\n\r\n1. Unaudited Financial Results:\r\nThe Unaudited Financial Results for the Quarter ended June 30 2025. A copy of the same is enclosed along with the Limited Review Report of the Statutory Auditors thereon in terms of SEBI (LODR) Regulations 2015.\r\n2. Approved revision/change in the following Policy/Code:\r\n? Nomination and Remuneration Policy.\r\n? Policy on Determination of Materiality of Events\r\n? Code of Conduct to Regulate Monitor and Report on Trading in Securities by Insiders.\r\n\r\nThe Meeting of the Board of Directors of the Company commenced at 03:30 p.m. and concluded at 04.10 p.m.\r\n\r\nKindly take the above information on your records.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=465823c6-ae25-464c-b89b-e9bb2254b879.pdf",
            "news_date": "2025-08-13 17:48:36"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that an earnings call will be held on Thursday August 14 2025 at 11.00 A.M. IST to discuss operational and financial performance of the Company for the quarter ended \r\nJune 30 2025. \r\n\r\nThe invite giving requisite details including the pre-registration link and dial-in details is enclosed herewith. \r\n\r\nThe investor presentation shall be shared with the Exchanges separately.\r\n\r\nKindly take the information on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bbb970e3-cfcf-4072-8293-804f6504eee5.pdf",
            "news_date": "2025-08-07 17:44:52"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for  Unaudited Financial Results For The Quarter Ended On June 30 2025",
            "news_body": "Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday August 13 2025 inter alia to Consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30 2025. \r\n\r\nThis is to further inform you that in accordance with the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company by Designated Persons and their immediate relatives is closed from July 1 2025 till 48 hours after declaration of Unaudited Financial Results on August 13 2025.\r\n\r\nKindly take the above information on your records.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3af4743-dce0-4f69-b37a-765119e1f61b.pdf",
            "news_date": "2025-08-06 19:28:42"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Clarification Regarding Shareholder Demat Requests",
            "news_body": "Company has provided Clarification regarding Demat requests received erroneously from Shareholders of Supriya Pharmaceuticals Limited which is not related to Supriya Lifescience Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ff01c0d-61e2-4861-85b3-20d83f559b4c.pdf",
            "news_date": "2025-07-23 17:33:56"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to relevant provisions of the SEBI (LODR) Regulations 2015 we would like to inform you that the officials of our Company will be interacting with Analyst/Institutional Investors on Friday July 25 2025 as per the details mentioned in the attached communication.\r\n\r\nKindly take the same on records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76f63b88-70b9-48d8-9546-743843a3fb5b.pdf",
            "news_date": "2025-07-18 17:19:56"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to relevant provisions of the SEBI (LODR) Regulations 2015 we would like to inform you that the officials of our Company will be interacting with Analyst/ Institutional Investors on Thursday July 24 2025 as per the details mentioned in the attached communication.\r\n\r\nKindly take the same on records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14416df3-18b4-4f82-8c00-23f4f7e9b673.pdf",
            "news_date": "2025-07-17 17:19:26"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find enclosed herewith duly signed certificate issued by MUFG Intime India Private Limited our RTA confirming compliance under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2025.\r\n\r\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa7dd14c-9c79-4f2d-9419-66a6284ff393.pdf",
            "news_date": "2025-07-11 10:39:26"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Disclosure under Regulation 30 of the SEBI (LODR) Regulations 2015 for details of Show cause cum demand notice received from Office of the Commissioner of CGST & C.Ex Mumbai.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f664a0c1-05d4-43d5-9010-2c9d49f991fd.pdf",
            "news_date": "2025-07-01 16:47:40"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddd9d4d9-f805-4bdb-b050-88a2f2dc82b5.pdf",
            "news_date": "2025-06-27 16:53:21"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Email Communication To Shareholders Regarding Dividend Taxation Provisions",
            "news_body": "Email communication to shareholders regarding taxation provisions.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c98dfe4-d858-4b00-9d09-7d7b7ade04e4.pdf",
            "news_date": "2025-06-17 17:31:55"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached Earnings Call Transcript for the Earnings call held on May 28 2025 with respect to Audited Financial Results of the Company for the quarter and year ended March 31 2025.",
            "news_id": "c06c3f73-eee6-4892-92ba-9b1b854c08aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62c18ff5-eee2-4b37-8b91-6b41787e6bb4.pdf",
            "news_date": "2025-05-31 17:14:56",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached Earnings Call Transcript for the Earnings call held on May 28 2025 with respect to Audited Financial Results of the Company for the quarter and year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62c18ff5-eee2-4b37-8b91-6b41787e6bb4.pdf",
            "news_date": "2025-05-31 17:14:56"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Please find enclosed herewith Annual Secretarial Compliance Report for the year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d4bfc1d-e52d-48f0-a263-9db7f29665db.pdf",
            "news_date": "2025-05-28 15:02:13"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached Audio Recording of Earnings Call.",
            "news_id": "cdf43898-2220-463b-b6f8-4aff5983541f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d3b53f7-2555-4fb0-b5cd-b65668e75c3e.pdf",
            "news_date": "2025-05-28 14:48:52",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached Audio Recording of Earnings Call.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d3b53f7-2555-4fb0-b5cd-b65668e75c3e.pdf",
            "news_date": "2025-05-28 14:48:52"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith Newspaper Publication of Audited Financial Results for March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=325002e1-369a-4217-bf38-dd3349dde440.pdf",
            "news_date": "2025-05-28 14:42:45"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please find attached herewith Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe85677d-8fc6-41b2-9d78-c86ce89fa115.pdf",
            "news_date": "2025-05-28 14:37:47"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation.",
            "news_id": "c42e467b-680e-43a3-8da4-8ddd7d3711a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50d4116b-de86-4332-8c93-b9b8989dad88.pdf",
            "news_date": "2025-05-27 19:42:29",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50d4116b-de86-4332-8c93-b9b8989dad88.pdf",
            "news_date": "2025-05-27 19:42:29"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Dividend Updates",
            "caption": "Announcement under Regulation 30 (LODR)-Dividend Updates",
            "news_body": "Recommended Dividend of Final Dividend of Re. 1.00 (Rupee 1.00/-) per equity share i.e. 50% on the face value of Rs. 2/- each  subject to approval of shareholders at the ensuing Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ccfde41-0fe1-4dbe-ab59-e38dc050dd88.pdf",
            "news_date": "2025-05-27 18:44:58"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Secretarial Auditor For Term Of Five (5)  Consecutive Years",
            "news_body": "Appointment of Auditors for Term of five (5) consecutive years",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ec02388-7c2e-4928-95da-2d8e7f2adacb.pdf",
            "news_date": "2025-05-27 18:16:14"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Intimation",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board to consider Dividend",
            "news_body": "Board recommended Final Dividend at its meeting held on May 27 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a6b4298-785d-44c0-9a2d-67a5d79076a1.pdf",
            "news_date": "2025-05-27 18:10:57"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Result For Quarter And Year Ended On March 31 2025",
            "news_body": "Audited Financial Results for the year ended March 31 2025",
            "news_id": "814d4fe4-42b5-4b4c-9d3d-ba62f1ea9574",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6a54abc-a2db-4bbc-9afa-ef4b859c5994.pdf",
            "news_date": "2025-05-27 18:09:03",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Result For Quarter And Year Ended On March 31 2025",
            "news_body": "Audited Financial Results for the year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6a54abc-a2db-4bbc-9afa-ef4b859c5994.pdf",
            "news_date": "2025-05-27 18:09:03"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On May 27 2025",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its Meeting held on Tuesday May 27 2025 inter-alia considered and approved the following:\r\n1. Audited Financial Results\r\n2. Dividend\r\n3. Appointment of Secretarial Auditors\r\nThe Meeting of the Board of Directors of the Company commenced at 03:30 p.m. and concluded at 04.10 p.m.\r\nKindly take the above information on your records.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f041fd49-7b1d-4eeb-b9e1-74394626df00.pdf",
            "news_date": "2025-05-27 17:53:02"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that an earnings call will be held on Wednesday May 28 2025 at 11.00 A.M. IST to discuss operational and financial performance of the Company for the quarter and year ended March 31 2025. \r\n\r\nThe invite giving requisite details including the pre-registration link and dial-in details is enclosed herewith. \r\n\r\nThe investor presentation shall be shared with the Exchanges separately.\r\n\r\nKindly take the information on record.\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14c82762-5414-41e3-af1f-f0e50c9b1a7a.pdf",
            "news_date": "2025-05-21 17:18:47"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Year Ended March 31 2025 And Recommend Dividend If Any On The Equity Shares Of The Company For The Financial Year Ended March 31 2025",
            "news_body": "Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday May 27 2025 inter alia to:\r\n\r\n1. Consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31 2025. \r\n2. Recommend dividend if any on the Equity Shares of the Company for the financial year ended March 31 2025.  \r\n\r\nThis is to further inform you that in accordance with the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company by Designated Persons and their immediate relatives is closed from April 1 2025 till 48 hours after declaration of Audited Financial Results on May 27 2025.\r\n\r\nKindly take the above information on your records.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=358fa6f6-802c-4a7e-a395-6c42b140f0cc.pdf",
            "news_date": "2025-05-20 17:16:05"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Compliance",
            "descriptor": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ",
            "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
            "news_body": "  <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Supriya Lifescience Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L51900MH2008PLC180452</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>A+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>ICRA LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table>  <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Prachi Sathe <br/>  Designation: Company Secretary and Compliance Officer <br/> EmailId: cs@supriyalifescience.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Krishna Raghunathan <br/> Designation: Chief Financial Officer <br/> EmailId: cs@supriyalifescience.com</div> </div> <div> <br/> Date: 28/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9025c6a2-e024-4459-91cc-3e5eb8a477e5.pdf",
            "news_date": "2025-04-28 12:31:25"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "The Scrutinizers report & Voting Results for the Postal ballot conducted by the Company is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a401bd1-0870-49da-9cb1-24cfb5e9deaf.pdf",
            "news_date": "2025-04-24 17:12:44"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "The Voting Results and Scrutinizers Report for the Postal Ballot conducted by the Company is attached herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3d138cf-ab7e-4430-8c0f-24c2dd809ded.pdf",
            "news_date": "2025-04-24 17:10:37"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Enclosed herewith details of Analyst/Institutional Investor Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db1c47f7-6e47-4807-af01-c8908a2db12b.pdf",
            "news_date": "2025-04-15 17:28:20"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Company has informed exchanges about certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff58fd8f-b95a-4f3a-aad1-87f9017f73ef.pdf",
            "news_date": "2025-04-11 16:56:55"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Enclosed herewith details of Analyst/Institutional Investor Meetings.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd5e5156-ccc2-41d7-8d5b-cafd5df320d2.pdf",
            "news_date": "2025-04-01 17:16:37"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e22f4636-5a30-48d1-846f-9f71a1ce3368.pdf",
            "news_date": "2025-03-26 17:26:16"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Enclosed herewith Newspaper Publication for Postal Ballot.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51ad3759-adee-4347-a018-cf2c8162c792.pdf",
            "news_date": "2025-03-25 16:38:09"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Please find attached Postal Ballot Notice of Supriya Lifesciences Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f1cc707-6243-4310-8506-a3b43485fda1.pdf",
            "news_date": "2025-03-24 16:24:00"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 the details of the Analyst/ Investor Meetings to be attended by the Company are enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c3f56cc-7e84-4a9e-97d8-82b4e7ae2e0f.pdf",
            "news_date": "2025-03-17 17:46:29"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Details Of Key Managerial Personnel Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Please find attached the details of KMP",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7120a39-f1c6-4bc4-af73-d4a37664c294.pdf",
            "news_date": "2025-03-10 15:46:08"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "The Board of Directors at their meeting held on March 10 2025 inter alia have considered and approved the \r\n1.appointment of Ms. Prachi Sathe bearing Membership No. A- 70252 as the Company Secretary and Compliance Officer of the Company with effect from March 10 2025\r\n2. Any other matter incidental to the appointment of Company Secretary and Compliance Officer.\r\n\r\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4deb3354-7797-4bd7-a6bb-51cfd863847d.pdf",
            "news_date": "2025-03-10 15:24:34"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "The Board of Directors at their meeting held on March 10 2025 inter alia considered and approved:\r\n1. Appointment of Ms. Prachi Sathe bearing Membership No. A-70252 as Company Secretary & Compliance Officer of the Company with effect from March 10 2025 on the basis of recommendations received from the Nomination and Remuneration Committee of the Company;\r\n2. Any other matters incidental with the appointment of Company Secretary and Compliance Officer.\r\nThe details required as per SEBI Circular dated 09.09.2025 and Brief profile is attached herewith.\r\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80c31f28-9f94-44bc-bbbb-39aeb30a53e1.pdf",
            "news_date": "2025-03-10 15:20:33"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held To Consider Appointment Of Company Secretary And Compliance Officer Of The Company.",
            "news_body": "With reference to above subject matter and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Board of Directors of the Company at their meeting held on Monday March 10 inter alia considered and approved the following businesses: \r\n1. Appointment of Ms. Prachi Sathe bearing Membership No. A-70252 as Company Secretary and Compliance Officer of the Company with effect from March 10 2025 on the basis of recommendations received from the Nomination and Remuneration Committee of the Company;\r\n2. Any other matters incidental with the appointment of Company Secretary and Compliance Officer of the Company;\r\nBrief profile as per SEBI circular is attached.\r\nThe Meeting of the Board of Directors of the Company commenced at 11.30 a.m. and concluded at 12.00 noon.\r\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8f9a69c-daa0-4101-b1ea-fe0bf7b40b20.pdf",
            "news_date": "2025-03-10 12:28:44"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Appointment Of Company Secretary And Compliance Officer Of The Company",
            "news_body": "Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/03/2025 inter alia to consider and approve With reference to above subject matter and pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the meeting of the Board of Directors of the Company will be held on Monday March 10 2025 at 11.30 a.m at the registered office of the Company to consider and transact the following businesses: \r\n1. Appointment of Company Secretary and Compliance Officer of the Company;\r\n2. Any other matter with the permission of the chair.\r\nKindly take the above information on your records.\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b02b3e3-c410-4c9b-b5db-97225a010fe4.pdf",
            "news_date": "2025-03-05 16:01:36"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2f2ec0f-783b-45ea-8fd4-ce6112ef1ac2.pdf",
            "news_date": "2025-02-26 16:26:26"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc87f419-39c2-4502-a9c1-d1db14375a93.pdf",
            "news_date": "2025-02-26 16:22:59"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44961d7c-0755-42ff-a8ed-4e98a021afe1.pdf",
            "news_date": "2025-02-26 16:20:27"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16b284ce-8e0d-47d4-8b60-e56c4d518e25.pdf",
            "news_date": "2025-02-25 13:10:42"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=797c56c6-0057-47ec-a5e6-f0b5a5de9819.pdf",
            "news_date": "2025-02-18 17:09:07"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3c94380-5d54-44e1-a9c1-42bf46f6110f.pdf",
            "news_date": "2025-02-10 14:22:44"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b94d311-f4c5-4999-9a18-023f48fa013e.pdf",
            "news_date": "2025-02-10 14:19:55"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Intimation of retirement of Two Independent Directors upon completion of two consecutive terms in office",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfc8bb4f-3218-4def-8255-84a1d8dd628e.pdf",
            "news_date": "2025-02-01 14:35:21"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call for the quarter and nine months ended December 31 2024",
            "news_id": "be423253-29a4-4a03-a2fc-ce9045eb1b71",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d9a141a-aa89-4d05-aa94-5e54666c355c.pdf",
            "news_date": "2025-01-31 12:40:36",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call for the quarter and nine months ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d9a141a-aa89-4d05-aa94-5e54666c355c.pdf",
            "news_date": "2025-01-31 12:40:36"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find the attachment.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f07e8281-0f07-4753-ab79-9fd8c5080448.pdf",
            "news_date": "2025-01-27 16:09:55"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Audio Recording Of Earnings Call",
            "news_body": "Please find the attachment.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b582043-3fef-4164-a11e-0d1de3b715ef.pdf",
            "news_date": "2025-01-27 16:07:40"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release (Revised)",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)",
            "news_body": "Please find attached herewith revised Press Release.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60db1ed2-46b8-496a-9e8a-479f8b12457b.pdf",
            "news_date": "2025-01-27 10:08:21"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please find the attachment.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ca74f5a-6fb0-40f2-82ef-ceaea8b96e5a.pdf",
            "news_date": "2025-01-25 11:38:36"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find the attachment.",
            "news_id": "cb764e42-6141-4aea-9a14-a09fc38aebcd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c01a1a9-c171-4e0f-98a4-19c447700df9.pdf",
            "news_date": "2025-01-24 21:44:14",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find the attachment.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c01a1a9-c171-4e0f-98a4-19c447700df9.pdf",
            "news_date": "2025-01-24 21:44:14"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "As attached.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db252909-72ee-4ed6-9624-c89909c283c9.pdf",
            "news_date": "2025-01-24 21:37:21"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Company Secretary / Compliance Officer",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
            "news_body": "Please find attachment.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4522196-74ff-4f04-ab57-bacdd713951b.pdf",
            "news_date": "2025-01-24 17:19:56"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Details Of Key Managerial Personnel Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Please find the attachment.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c55b1c5b-7ad7-46e7-8e75-a4fa2d9a255e.pdf",
            "news_date": "2025-01-24 17:09:44"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Please find the attachment.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4030e257-224e-40e1-8454-14584ab623ee.pdf",
            "news_date": "2025-01-24 17:01:20"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Month Ended December 31 2024",
            "news_body": "As attached.",
            "news_id": "e32bf3ea-33a7-47a9-8cf8-55dde020f154",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26b06b6d-9ea1-4192-98f2-ab751ff84f68.pdf",
            "news_date": "2025-01-24 16:24:48",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75656,
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Month Ended December 31 2024",
            "news_body": "As attached.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26b06b6d-9ea1-4192-98f2-ab751ff84f68.pdf",
            "news_date": "2025-01-24 16:24:48"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attachment.",
            "news_id": "64ead9c8-698f-4b1a-ba2f-e3b73e4ceaa5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48bdf40f-f558-438d-96c9-3206b57c3bc5.pdf",
            "news_date": "2024-11-04 15:17:15",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed.",
            "news_id": "74d0d80b-e6c2-4c62-8c7c-6be196fdd8ac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc464cb2-a0e1-4f6b-8fd0-0eace312c6aa.pdf",
            "news_date": "2024-10-28 13:52:41",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Please find attachemnt.",
            "news_id": "22d8ecdb-6347-4b73-9fee-53dc7c6e2125",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=915b66eb-a9ab-40a4-bfe4-5fa7a8828e05.pdf",
            "news_date": "2024-10-28 13:49:32",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find the attachment.",
            "news_id": "a7a2392c-167a-4087-b1a3-ed608e06ec18",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f79df80d-ff2b-40da-9359-0faabfb7f2a5.pdf",
            "news_date": "2024-08-19 10:34:40",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find the attachment.",
            "news_id": "b2dd0ac4-355f-47bd-a116-b504b666c732",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77f606ae-2674-4096-b94c-b5bda1294605.pdf",
            "news_date": "2024-08-10 14:45:19",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "Please find the attachment.",
            "news_id": "b1866713-1899-401f-a996-36155d29d7fe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=279db8d9-d747-4564-9735-26f9906d6fde.pdf",
            "news_date": "2024-08-10 14:18:20",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attachment.",
            "news_id": "dd94dcfa-ede8-4181-ac7d-7d801849ad95",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64845815-5ac2-4c3c-b20b-438ab9f17849.pdf",
            "news_date": "2024-06-05 13:08:21",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earning Call",
            "news_body": "Please find attached herewith Audio recording of earning call.",
            "news_id": "8e08a8f7-87e3-4e89-8edb-c51279f006e3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8817fa8d-dc3e-4788-8432-271ba5010e25.pdf",
            "news_date": "2024-05-29 15:56:08",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find the attachment.",
            "news_id": "bda280a7-3b78-429d-ab6f-bc2daf6dfcc2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50f334bb-a063-408b-a5ad-e08a42b4d7d3.pdf",
            "news_date": "2024-05-28 18:52:40",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2024",
            "news_body": "Please find the attachment.",
            "news_id": "70d29c69-8b14-4536-8a2a-631caadac698",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78ede806-162e-4d25-b43f-333aa04651dd.pdf",
            "news_date": "2024-05-28 18:31:46",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find the attachment.",
            "news_id": "9a008f98-c15d-4bbb-a3ae-161c75071827",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0e8c1fc-fd56-4e33-9251-21abd087ea97.pdf",
            "news_date": "2024-02-13 11:28:22",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attachment.",
            "news_id": "b0ada8b6-8be7-4183-88c8-e0595d604107",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd06c887-1cb7-4bbc-92ee-8922102ca7f8.pdf",
            "news_date": "2024-02-07 18:04:32",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Please find attachment.",
            "news_id": "a0ce1b2c-12cd-4cb9-ab1f-f5ae2128d63e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=599cf7b3-8048-4e69-8b8c-0c0b7c95e139.pdf",
            "news_date": "2024-02-07 17:44:46",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith Earning call transcript.",
            "news_id": "2e52fe34-d662-4053-8e61-93b1640ebcd2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b7c5a16-3471-4932-a4c0-8f5ab29ef970.pdf",
            "news_date": "2023-11-13 14:46:39",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Investor Presentation.",
            "news_id": "2d1e2247-f983-4293-a982-1693616c5fc4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09988bf0-906f-468b-8895-7c26efda1844.pdf",
            "news_date": "2023-11-07 17:33:55",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "Please find attachment.",
            "news_id": "e677ff88-f085-44f1-a048-ca8b50060851",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b2ece4a-67f1-4f27-80b7-cd32e0770521.pdf",
            "news_date": "2023-11-07 16:55:01",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith Earning Call Transcript.",
            "news_id": "b094985a-747e-4afe-bc16-818f733ebe56",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73f38be3-d0e7-45e1-ae7e-e832ce56f83e.pdf",
            "news_date": "2023-08-08 15:41:29",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Call",
            "news_body": "Please find enclosed audio recording of Earning Call.",
            "news_id": "481937b1-9111-4a3d-88d2-c7b56bb8acc8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee21b016-f030-46d5-a5a1-a25612a1d16c.pdf",
            "news_date": "2023-08-04 13:12:23",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Investor Presentation.",
            "news_id": "5adc823c-3b2f-414a-9504-1efc4c532810",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b59688e5-318c-4c64-a2a9-3c1a6c9c66e9.pdf",
            "news_date": "2023-08-03 18:01:16",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "Enclosing Unaudited Financial Results for the quarter ended June 30, 2023.",
            "news_id": "f5358410-6f44-42e6-85c0-7343649b3de2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d617a252-199a-49ce-83fb-f52d1f8a36e0.pdf",
            "news_date": "2023-08-03 17:35:34",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Thursday, August 3, 2023, inter-alia, has considered and approved the Unaudited Financial Results for the Quarter ended June 30, 2023.<BR> <BR> We hereby enclose the following:<BR> <BR> 1. Copy of the Unaudited Financial Results of the Company for the quarter ended June 30, 2023 along with the Limited Review report issued by Statutory Auditor;<BR> <BR>",
            "news_id": "1af40063-0b39-4df9-9bc0-5a84919bd6f7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4718a886-1fc1-4f2c-b5f4-88b5a341f0cd.pdf",
            "news_date": "2023-08-03 17:29:42",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Monday, May 29, 2023 at 11.00 A.M. IST to discuss operational and financial performance of the Company for the Fourth Quarter and Year ended of FY 2022-2023 (Q4 & FY23).",
            "news_id": "35ec0855-994c-4fcc-b9c9-1d434df28acb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4883bda2-246a-4207-aedb-0394f02dc9ed.pdf",
            "news_date": "2023-06-02 10:10:37",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Call",
            "news_body": "In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company''s Earnings Call held today (i.e., May 29, 2023) regarding discussion on operational and financial performance for the Fourth Quarter and Year ended of FY 2022-2023 (Q4 & FY23) is available on the Company''s website.",
            "news_id": "072fe865-5e73-4230-b57c-e7aa125c3b70",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa3e8174-b7b8-4792-9fed-d6e4a2fb0751.pdf",
            "news_date": "2023-05-29 13:08:49",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation.",
            "news_id": "0f7610c9-5a12-436b-a739-8f32efd54822",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f6c044d-3251-4f68-a72a-feae1caf605d.pdf",
            "news_date": "2023-05-27 21:43:37",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2023",
            "news_body": "Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Friday, May 26, 2023 considered and approved the Audited Financial Results for the Quarter and year ended March 31, 2023.",
            "news_id": "27713033-ca02-4c9d-a3e0-7a986d952ffe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8038c4d4-4691-4aed-ad40-558c04d9d8aa.pdf",
            "news_date": "2023-05-26 14:55:22",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Wednesday, February 15, 2023, at 11.00 A.M. IST to discuss operational and financial performance of the Company for the quarter and nine month ended December 31, 2022.",
            "news_id": "08dd6560-1256-40a0-86e8-af58af556888",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a846f30-3ba6-452c-bac1-63737c98e0af.pdf",
            "news_date": "2023-02-20 14:39:41",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Call",
            "news_body": "In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company''s Earnings Call held today (i.e., February 15, 2023) regarding discussion on operational and financial performance for the third Quarter and nine months ended of FY 2022-2023 (Q3 & 9M FY23) is available on the Company''s website.",
            "news_id": "8296a883-4864-4e1f-afc3-45e9a2c1f6fc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55626bc7-9a1f-4339-bc11-faf53d2904e8.pdf",
            "news_date": "2023-02-15 14:11:25",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation.",
            "news_id": "fbc67d0b-4477-4f0c-b94f-fb274c6035d3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79289ee6-b211-4ec3-a8eb-ef14d0931059.pdf",
            "news_date": "2023-02-14 19:34:22",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022.",
            "news_body": "We hereby enclose the following:1. Copy of the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022 along with the Limited Review report issued by Statutory Auditor;",
            "news_id": "819f694c-cf14-41ad-95b8-8f4c959a6c5f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ba7dd1b-71fc-47e8-81e0-038e2dc65c0c.pdf",
            "news_date": "2023-02-14 17:38:07",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Friday, November 11, 2022 at 4.00 P.M. IST to discuss operational and financial performance of the Company for the quarter and half year ended September 30, 2022.",
            "news_id": "bb759cec-a658-4fb1-a040-1ecd7a7c4784",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b885104f-c5fc-4c36-898d-f4fd9e7d1fab.pdf",
            "news_date": "2022-11-17 17:47:48",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of Related Party Transactions for the half year ended September 30, 2022.",
            "news_id": "502d2889-03ad-4e61-b574-13b8d156f14a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6f3ef9e-5ca2-47be-b0a9-80f4e238dbc2.pdf",
            "news_date": "2022-11-17 16:15:26",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Call",
            "news_body": "In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company''s Earnings Call held today (i.e., November 11, 2022) regarding discussion on operational and financial performance for the Second Quarter of FY 2022-2023 (Q2) is available on the Company''s website.The recording can be accessed from the link given below:https://supriyalifescience.com/investor-relation/financial/earning-call-recordings/",
            "news_id": "d14cea9c-d031-4eb3-acb9-28e7cd885a51",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89fad0ce-8afa-48a3-bb8b-38bf2c17f2a7.pdf",
            "news_date": "2022-11-11 18:20:24",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Six Months Ended September 30, 2022 (Revised)",
            "news_body": "We hereby enclose the following:<BR> <BR> 1. Copy of the Revised Unaudited Financial Results of the Company for the quarter and six months ended September 30, 2022 along with the Limited Review report issued by Statutory Auditor;",
            "news_id": "cb11ed15-ca47-4f8e-b759-290dea30cea4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a8cd5f6-d80f-456a-9cac-b5972f231d62.pdf",
            "news_date": "2022-11-11 14:22:07",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation.You are requested to kindly take the same on record.",
            "news_id": "ac0324d8-41cf-4f72-96d4-3a5fae2ca90d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7eeb9c5-5519-4c0e-995a-34bd5908e7fe.pdf",
            "news_date": "2022-11-11 09:43:34",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Six Months Ended September 30, 2022 (Revised)",
            "news_body": "We hereby enclose the following:<BR> <BR> 1. Copy of the Revised Unaudited Financial Results of the Company for the quarter and six months ended September 30, 2022 along with the Limited Review report issued by Statutory Auditor; <BR>",
            "news_id": "b8d6cb41-7e6e-46e7-8143-f2ebe9478e5d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b6906f2-9f9f-4995-bbef-7aed31bea0c9.pdf",
            "news_date": "2022-11-10 20:09:06",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Six Months Ended September 30, 2022.",
            "news_body": "We hereby enclose the following:<BR> <BR> 1. Copy of the Unaudited Financial Results of the Company for the quarter and six months ended September 30, 2022 along with the Limited Review report issued by Statutory Auditor;<BR> <BR>",
            "news_id": "ac04bd14-dc4d-49cc-b267-25d67762596c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bde5e94d-64bb-4289-a2d1-cb1321da4062.pdf",
            "news_date": "2022-11-10 17:24:02",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Thursday, November 10, 2022, inter-alia, has:<BR> <BR> 1. Considered and approved the Unaudited Financial Results for the Quarter and six months ended September 30, 2022.<BR> 2. Approved appointment of M/s. DSM & Associates, Practising Company Secretaries as Secretarial Auditor for the financial year 2022-23;<BR> 3. Approved appointment of M/s. Nair's & Panicker's, Audit & Advisory Services, as Internal Auditor for the financial year 2022-23;<BR>",
            "news_id": "66682cf9-98b0-467b-be99-c33fb741ce2c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=522ab542-4d49-42d8-96b7-ddfd20fc27a3.pdf",
            "news_date": "2022-11-10 17:16:43",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Tuesday, August 16, 2022 at 3.00 P.M. IST to discuss operational and financial performance of the Company for the quarter ended June 30, 2022 (Q1 of FY 2022-23).This is for your information and records.",
            "news_id": "6cffe024-3fa2-480b-af0b-0f4017bbe604",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cec37817-13e4-4ed4-bc95-342536ee3222.pdf",
            "news_date": "2022-08-23 18:04:34",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Call",
            "news_body": "In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company''s Earnings Call held today (i.e., August 16, 2022) regarding discussion on operational and financial performance for the First Quarter of FY 2022-2023 (Q1) is available on the Company''s website.The recording can be accessed from the link given below:https://supriyalifescience.com/investor-relation/financial/earning-call-recordings/You are requested to kindly take the same on record.",
            "news_id": "8e96051e-e5ff-4a65-8f8f-9ddeb84351aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ae7b848-0e6d-492d-afdf-93a7f608b9a1.pdf",
            "news_date": "2022-08-16 17:48:48",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation. You are requested to kindly take the same on record.",
            "news_id": "c15410ee-60df-4cfd-8556-eafdfb74d967",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d40d8956-9286-4986-a339-b9b6ffa213f7.pdf",
            "news_date": "2022-08-13 14:39:31",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Friday, August 12, 2022, inter-alia, has:<BR> <BR> 1. Considered and approved the Unaudited Financial Results for the Quarter ended June 30, 2022.<BR> 2. Recommended re-appointment of M/s. Kakaria & Associates LLP, Chartered Accountants (Firm Registration No. 104558W/W100601) as the Statutory Auditors of the Company, for second term of five years from the conclusion of the ensuing 14th AGM till the conclusion of the 19th  AGM to be held in the year 2027, subject to approval of the members at the ensuing 14th AGM..<BR>",
            "news_id": "d37316cd-fa7e-4a00-bcf4-b17da7718a23",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=295a2fbd-c4b2-406f-b9b5-9e23d6b8cece.pdf",
            "news_date": "2022-08-12 19:24:43",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Friday, August 12, 2022, inter-alia, has:<BR> 1. Considered and approved the Unaudited Financial Results for the Quarter ended June 30, 2022.<BR> 2. Recommended re-appointment of M/s. Kakaria & Associates LLP, Chartered Accountants (Firm Registration No. 104558W/W100601) as the Statutory Auditors of the Company, for second term of five years from the conclusion of the ensuing 14th AGM till the conclusion of the 19th  AGM to be held in the year 2027, subject to approval of the members at the ensuing 14th AGM..<BR>",
            "news_id": "58d830a6-0d30-4750-8534-d0a6abca85c8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2874ef68-9297-4366-922b-82bee408771b.pdf",
            "news_date": "2022-08-12 19:19:39",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Monday, May 23, 2022 at 3.30 P.M. IST to discuss operational and financial performance of the Company for the fourth quarter and year ended March 31, 2022.This is for your information and records.",
            "news_id": "a4dd1c4c-7015-424b-84a0-7523e24e9dd7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d3d9594-3217-4860-aab2-a89d8198f7cd.pdf",
            "news_date": "2022-05-27 20:20:22",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Call",
            "news_body": "In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company''s Earnings Call held today (i.e., May 23, 2022) regarding discussion on operational and financial performance for the Fourth Quarter and Financial Year ended March 31, 2022 (Q4 and FY 2021-22) is available on the Company''s website.The recording can be accessed from the link given below:https://supriyalifescience.com/investor-relation/financial/earning-call-recordings/ Kindly take the information on record.",
            "news_id": "6df0de99-fd73-447b-8fe8-b26b0babdb7e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cbeef86-6af8-42eb-b1b3-c24166ea3a48.pdf",
            "news_date": "2022-05-23 18:44:22",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "This has a reference to our intimation letter dated May 21, 2022, wherein the Company has submitted Investor Presentation, inter-alia, to the Stock Exchanges.In connection herewith, please find enclosed herewith revised Investor presentation.You are requested to kindly take the same on record.",
            "news_id": "e91eb2ab-87e6-4e0f-bc6c-ec37ced9c621",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=934c72b2-b8dd-44ae-ad0b-43845e491116.pdf",
            "news_date": "2022-05-21 17:27:33",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation.You are requested to kindly take the same on record.",
            "news_id": "df3aff27-fb5e-4988-9351-57ac48f76641",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=233dd6f0-bae1-4a8f-bb7c-0b68950be365.pdf",
            "news_date": "2022-05-21 15:23:31",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2022",
            "news_body": "Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Friday, May 20, 2022, inter-alia, has:<BR> <BR> 1. Considered and approved the Audited Financial Results for the Quarter and year ended March 31, 2022.<BR> 2. Recommended the Final Dividend of Rs. 0.60 per equity share (face value of Rs. 2/- each) subject to approval of shareholders in the ensuing Annual General Meeting.<BR> <BR>",
            "news_id": "42477761-c145-4816-a349-1b8c82d4b91f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fb2bc2f-dd16-4fea-aeb1-8c2f874bfd1d.pdf",
            "news_date": "2022-05-20 16:59:08",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Friday, May 20, 2022, inter-alia, has:<BR> <BR> 1. Considered and approved the Audited Financial Results for the Quarter and year ended March 31, 2022.<BR> 2. Recommended the Final Dividend of Rs. 0.60 per equity share (face value of Rs. 2/- each) subject to approval of shareholders in the ensuing Annual General Meeting.<BR> <BR> The Financials Results will be published in newspapers as required under the Listing Regulations.<BR> <BR> The Meeting of the Board of Directors of the Company commenced at 03:00 p.m. and concluded at 04:30 p.m.<BR> <BR> <BR>",
            "news_id": "e1528b85-9d2a-494d-a877-e963cd08f23a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b680f59-9344-4a30-82a0-2f3eddb5fc58.pdf",
            "news_date": "2022-05-20 16:55:33",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Friday, January 21, 2022 at 4.00 P.M. IST to discuss operational and financial performance of the Company for the quarter and nine months ended December 31, 2021 (Q3 of FY 2021-22).This intimation is also being made available on the website of the Company at:https://supriyalifescience.com/investor-relation/ Kindly take the information on record.",
            "news_id": "bc6d6046-a3f8-4014-a9df-0f333b115574",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f36fd37-4c88-43a9-b9b5-6629e3f437b5.pdf",
            "news_date": "2022-01-25 17:31:54",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter And Nine Months Ended On December 31, 2021 (Revised)",
            "news_body": "This has reference to our letter dated January 21, 2022 regarding submission of Unaudited Financial Results for the Quarter and nine months ended December 31, 2021 pursuant to regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015.In this connection, we would like to inform that the aforesaid unaudited results submitted to stock exchanges contain clerical error caused inadvertently.Since only the Sr. No. VII & XV contains error, we affirm that there are no other changes in the  Statement of Unaudited Financial Results for the for the Quarter and nine months ended December 31, 2021. We sincerely regret the inconvenience caused in this regard.  Kindly take revised Unaudited Financial Statement on your records.",
            "news_id": "30802550-fc33-4677-a124-4ca0ce7d80b6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92d2e550-a70f-4023-a966-0a77c960e2e9.pdf",
            "news_date": "2022-01-21 16:06:26",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation. You are requested to kindly take the same on record.",
            "news_id": "638768c9-3419-4398-a536-e1d2fff2e11d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5475add-1293-4210-9c85-293bd7c06cdb.pdf",
            "news_date": "2022-01-21 13:58:59",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2021 Along With The Limited Review Report.",
            "news_body": "The Board of Directors of Company at its meeting held on January 21, 2022, has, inter alia, considered and approved the Unaudited Financial Results of the for the Quarter and nine months ended December 31, 2021 along with the Limited Review Report.<BR> <BR> Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (Listing Regulations), we are enclosing a copy of the above mentioned Unaudited Financial Results along with the Limited Review Report of the Auditors. <BR> <BR> The Financials Results will be published in newspapers as required under the Listing Regulations.<BR> <BR> The Meeting of the Board of Directors of the Company commenced at 11.30 a.m. and concluded at 12.25 p.m.<BR> <BR> Kindly take the above said information on your records.<BR>",
            "news_id": "62b796d0-181e-49cb-9bef-50c082f97a9e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44718ec8-88d6-461f-91d6-eb9842921356.pdf",
            "news_date": "2022-01-21 12:48:57",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On January 21, 2022 In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "The Board of Directors of Company at its meeting held on January 21, 2022, has, inter alia, considered and approved the Unaudited Financial Results of the for the Quarter and nine months ended December 31, 2021 along with the Limited Review Report.<BR> <BR> Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (Listing Regulations), we are enclosing a copy of the above mentioned Unaudited Financial Results along with the Limited Review Report of the Auditors. <BR> <BR> The Financials Results will be published in newspapers as required under the Listing Regulations.<BR> <BR> The Meeting of the Board of Directors of the Company commenced at 11.30 a.m. and concluded at 12.25 p.m.<BR> <BR> Kindly take the above said information on your records.<BR>",
            "news_id": "c6d073e5-6116-4f0e-8a34-12f1623e8d6b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6a1f6f5-6471-46aa-b307-dd65dedcae8b.pdf",
            "news_date": "2022-01-21 12:46:10",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}